Woody JN - Search Results

1

Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2).

Elliott MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN. Elliott MJ, et al. Among authors: woody jn. Br J Rheumatol. 1997 May;36(5):589-93. doi: 10.1093/rheumatology/36.5.589. Br J Rheumatol. 1997. PMID: 9189062

2

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J, Woody JN. Elliot MJ, et al. Among authors: woody jn. Arthritis Rheum. 2008 Feb;58(2 Suppl):S92-S101. doi: 10.1002/art.23362. Arthritis Rheum. 2008. PMID: 18240199 Free article.

3

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.

Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Bijl H, Woody JN. Elliott MJ, et al. Among authors: woody jn. Lancet. 1994 Oct 22;344(8930):1125-7. doi: 10.1016/s0140-6736(94)90632-7. Lancet. 1994. PMID: 7934495 Clinical Trial.

4

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.

Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN. Paleolog EM, et al. Among authors: woody jn. Arthritis Rheum. 1996 Jul;39(7):1082-91. doi: 10.1002/art.1780390703. Arthritis Rheum. 1996. PMID: 8670315 Clinical Trial.

5

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

Feldmann M, Elliott MJ, Woody JN, Maini RN. Feldmann M, et al. Among authors: woody jn. Adv Immunol. 1997;64:283-350. doi: 10.1016/s0065-2776(08)60891-3. Adv Immunol. 1997. PMID: 9100984 Review. No abstract available.

6

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M. Maini RN, et al. Among authors: woody jn. Arthritis Rheum. 1998 Sep;41(9):1552-63. doi: 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W. Arthritis Rheum. 1998. PMID: 9751087 Clinical Trial.

7

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. Feldmann M, et al. Among authors: woody jn. Best Pract Res Clin Rheumatol. 2004 Feb;18(1):59-80. doi: 10.1016/j.berh.2003.09.010. Best Pract Res Clin Rheumatol. 2004. PMID: 15123038 Review.

8

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?

Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN. Feldmann M, et al. Novartis Found Symp. 2004;256:53-69; discussion 69-73, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027483 Review.

9

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.

Feldmann M, Maini RN, Woody JN, Holgate ST, Winter G, Rowland M, Richards D, Hussell T. Feldmann M, et al. Among authors: woody jn. Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9. Lancet. 2020. PMID: 32278362 Free PMC article. No abstract available.

10

T-cell-targeted immunotherapy.

Feldmann M, June CH, McMichael A, Maini R, Simpson E, Woody JN. Feldmann M, et al. Among authors: woody jn. Immunol Today. 1992 Mar;13(3):84-5. doi: 10.1016/0167-5699(92)90146-X. Immunol Today. 1992. PMID: 1622543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page